Resistance to second-line drugs in multidrug-resistant tuberculosis. Go to Publication You Might Also Like Why “covering all” in the DOTS program is not necessarily “all being covered” by the DOTS program. October 29, 2010 Bronchoalveolar lavage contamination by sterile containers: A unique and unrecognized cause of a false-positive galactomannan. December 25, 2017 Totally drug-resistant tuberculosis (TDR-TB) in India: every dark cloud has a silver lining. June 23, 2013 Possible impact of the standardized Category IV regimen on multidrug-resistant tuberculosis patients in Mumbai. May 6, 2016 Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India. March 22, 2017
Why “covering all” in the DOTS program is not necessarily “all being covered” by the DOTS program. October 29, 2010
Bronchoalveolar lavage contamination by sterile containers: A unique and unrecognized cause of a false-positive galactomannan. December 25, 2017
Totally drug-resistant tuberculosis (TDR-TB) in India: every dark cloud has a silver lining. June 23, 2013
Possible impact of the standardized Category IV regimen on multidrug-resistant tuberculosis patients in Mumbai. May 6, 2016
Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India. March 22, 2017